NIPA1 Gene

NIPA1 — Non-imprinted in Prader-Willi/Angelman Syndrome 1

Overview

Nipa1 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

NIPA1 (Non-imprinted in Prader-Willi/Angelman Syndrome 1) encodes a magnesium transporter protein that plays critical roles in neuronal function, synaptic transmission, and intracellular magnesium homeostasis. Mutations in NIPA1 are primarily associated with hereditary spastic paraplegia (HSP), but emerging research suggests potential roles in broader neurodegenerative processes including Alzheimer's disease (AD) and Parkinson's disease (PD). [@nipa2007]

NIPA1 — Non-imprinted in Prader-Willi/Angelman Syndrome 1

Overview

Nipa1 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Introduction

NIPA1 (Non-imprinted in Prader-Willi/Angelman Syndrome 1) encodes a magnesium transporter protein that plays critical roles in neuronal function, synaptic transmission, and intracellular magnesium homeostasis. Mutations in NIPA1 are primarily associated with hereditary spastic paraplegia (HSP), but emerging research suggests potential roles in broader neurodegenerative processes including Alzheimer's disease (AD) and Parkinson's disease (PD). [@nipa2007]

<div class="infobox infobox-gene"> [@magnesium2020]
<table> [@nipa2011]
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">Non-imprinted in Prader-Willi/Angelman Syndrome 1</th></tr> [@magnesium2018]
<tr><td><strong>Gene Symbol</strong></td><td>NIPA1</td></tr> [@nipa2019]
<tr><td><strong>Full Name</strong></td><td>Magnesium Transporter NIPA1</td></tr> [@stress2015]
<tr><td><strong>Chromosome</strong></td><td>9q21.13</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[64359](https://www.ncbi.nlm.nih.gov/gene/64359)</td></tr>
<tr><td><strong>OMIM</strong></td><td>[608456](https://www.omim.org/entry/608456)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000139970</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9BUE2](https://www.uniprot.org/uniprot/Q9BUE2)</td></tr>
<tr><td><strong>Protein Class</strong></td><td>Magnesium transporter (SLC family)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>Hereditary Spastic Paraplegia Type 6 (SPG6)</td></tr>
</table>
</div>

Molecular Biology and Biochemistry

Protein Structure

NIPA1 is a 317-amino acid transmembrane protein belonging to the SLC41A family of magnesium transporters^[1]. The protein contains 9-10 transmembrane domains and localizes primarily to the plasma membrane and endolysosomal compartments. Its structure includes a conserved magnesium transporter domain that facilitates Mg²⁺ ion flux across cellular membranes.

Magnesium Transport Function

NIPA1 functions as a Mg²⁺ ion channel with the following characteristics:

• Ion Specificity: Highly selective for magnesium over other divalent cations
• Transport Mechanism: Electrogenic Mg²⁺/H⁺ antiport mechanism
• pH Sensitivity: Activity modulated by intracellular pH
• Regulation: Controlled by cellular magnesium status and neuronal activity

• ATP binding and utilization
• RNA and DNA stability
• Protein synthesis
• Neuronal excitability

Expression Pattern

Brain Expression

NIPA1 exhibits widespread expression throughout the central nervous system with highest levels in:

• Cerebral [cortex](/brain-regions/cortex) (layers II-IV pyramidal neurons)
• [Hippocampus](/brain-regions/hippocampus) (CA1-CA3 pyramidal cells, dentate gyrus granule cells)
• Cerebellum (Purkinje cells)
• Spinal cord (corticospinal tract neurons)
• Dorsal root ganglia (sensory neurons)

Cellular Localization

In [neurons](/entities/neurons), NIPA1 localizes to:

• Somatic and dendritic plasma membranes
• Endoplasmic reticulum membranes
• Synaptic vesicles
• Axonal compartments

Physiological Functions

Neuronal Development

During neurodevelopment, NIPA1 regulates:

• Neuronal migration via magnesium-dependent signaling
• Axonal outgrowth and pathfinding
• Dendritic arborization
• Synapse formation and maturation

Synaptic Transmission

At the synapse, NIPA1 modulates:

• Presynaptic release probability through Mg²⁺ regulation
• Postsynaptic receptor function
• [Long-term potentiation](/mechanisms/long-term-potentiation) (LTP) and depression (LTD)
• Calcium signaling at synaptic terminals

Magnesium Homeostasis

Proper intracellular Mg²⁺ levels are essential for:

• [NMDA receptor](/entities/nmda-receptor) function
• Voltage-gated calcium channel regulation
• Adenylate cyclase activity
• Mitochondrial energy metabolism

Disease Associations

Hereditary Spastic Paraplegia Type 6 (SPG6)

Pathogenesis: Dominant NIPA1 mutations cause SPG6, characterized by progressive lower limb spasticity and weakness^[2].

| Feature | Description |
|---------|-------------|
| Inheritance | Autosomal dominant |
| Onset | Variable (adolescence to adulthood) |
| Core Symptoms | Lower limb spasticity, weakness, urinary urgency |
| Additional Features | Variable peripheral neuropathy, cognitive impairment |

Mechanism: Mutant NIPA1 proteins exhibit reduced magnesium transport activity, leading to:

• Impaired axonal transport
• Endoplasmic reticulum stress
• Dysregulated neuronal calcium signaling
• Progressive degeneration of corticospinal tract neurons

Alzheimer's Disease

Emerging evidence links NIPA1 to AD pathogenesis:

• [Amyloid-beta](/proteins/amyloid-beta) effects: Aβ oligomers downregulate NIPA1 expression
• Magnesium dysregulation: AD brain shows regional magnesium deficiency
• Synaptic dysfunction: NIPA1 loss impairs synaptic magnesium homeostasis
• Therapeutic potential: Magnesium supplementation may benefit AD patients^[3]

Parkinson's Disease

NIPA1 involvement in PD includes:

• Nigral vulnerability: High NIPA1 expression in substantia nigra pars compacta
• Magnesium metabolism: PD patients show cerebrospinal fluid magnesium alterations
• Mitochondrial function: NIPA1 regulates mitochondrial Mg²⁺ levels
• LRRK2 interaction: Potential genetic interactions with PD-risk genes

Amyotrophic Lateral Sclerosis (ALS)

• Motor neuron susceptibility: NIPA1 mutations may increase ALS risk
• glutamate excitotoxicity: Magnesium regulates NMDA receptor activity
• Energy metabolism: Motor neurons require precise Mg²⁺ homeostasis

Therapeutic Implications

Small Molecule Modulators

Pharmaceutical development focuses on:

• Mg²⁺ channel agonists: Enhance residual NIPA1 function
• Protein stabilizers: Correct misfolded mutant proteins
• ER stress inhibitors: Address downstream pathological pathways

Gene Therapy Approaches

Future therapeutic strategies include:

• Antisense oligonucleotides: Reduce toxic mutant protein expression
• CRISPR-based correction: Edit disease-causing mutations
• Viral vector delivery: Restore normal NIPA1 function

Research Methods

Experimental Models

• Cell lines: HEK293, SH-SY5Y neuroblastoma cells
• Animal models: Transgenic NIPA1 mutant mice, zebrafish models
• iPSC-derived neurons: Patient-specific neuronal models

Detection Techniques

• Western blotting: Protein expression analysis
• Immunohistochemistry: Tissue localization
• Mg²⁺ imaging: Fluorescent magnesium indicators (Mag-Fura-2, Mag Indo-1)
• Electrophysiology: Patch-clamp recordings of Mg²⁺ currents

Summary

NIPA1 is a critical magnesium transporter with essential roles in neuronal function and survival. While primarily associated with hereditary spastic paraplegia, emerging research reveals broader implications for neurodegenerative diseases including AD, PD, and ALS. Understanding NIPA1 function and developing therapeutic modulators represents a promising avenue for treating disorders of neuronal magnesium homeostasis.

Overview

Nipa1 Gene plays an important role in the study of neurodegenerative diseases. This page provides comprehensive information about this topic, including its mechanisms, significance in disease processes, and therapeutic implications.

Background

The study of Nipa1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

See Also

• - Protein product
• - Related disease
• - Related mechanism

External Links

• [NCBI Gene: NIPA1](https://www.ncbi.nlm.nih.gov/gene/123606)
• [UniProt: NIPA1](https://www.uniprot.org/uniprot/Q9UPV3)
• [GeneCards: NIPA1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=NIPA1)

References